Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Theravance Biopharma, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 115 | −3 |
| Shares | 52.8M | 1.84M | 50.8M | −130.7K (−0.3%) |
| Value | $546.3M | $19.1M | $438.5M | −$88.8M (−16.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Theravance Biopharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 2,008,253 | $17.3M | 0.02% |
| Highbridge Capital Management LLC | 227,300 | $1.96M | 0.11% |
| Dark Forest Capital Management LP | 31,733 | $273.9K | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 16,137 | $139.3K | 0.01% |
| Balyasny Asset Management LLC | 13,699 | $118.2K | 0.00% |
| Natixis | 2,000 | $17.3K | 0.00% |
| Aquatic Capital Management LLC | 1,600 | $14.0K | 0.00% |
| Parallel Advisors, LLC | 239 | $2.06K | 0.00% |
| Financial Synergies Wealth Advisors, Inc. | 80 | $691 | 0.00% |
| Farther Finance Advisors, LLC | 27 | $233 | 0.00% |
| JNBA Financial Advisors | 1 | $9 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
Sold out (15)
Institutions that held Theravance Biopharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Opaleye Management Inc. | 543,500 | $5.63M |
| Norges Bank | 451,338 | $4.67M |
| Two Sigma Advisers, LP | 94,300 | $976.0K |
| Two Sigma Investments, LP | 58,058 | $600.9K |
| Squarepoint Ops LLC | 48,706 | $504.1K |
| Franklin Resources Inc | 41,915 | $433.8K |
| STRS Ohio | 32,900 | $340.0K |
| Nebula Research & Development LLC | 31,472 | $325.7K |
| Bleakley Financial Group, LLC | 23,700 | $245.3K |
| Sawtooth Solutions, LLC | 23,688 | $245.2K |
| Graham Capital Management, L.P. | 14,662 | $151.8K |
| Fox Run Management, L.L.C. | 10,964 | $113.5K |
| Jump Financial, LLC | 10,434 | $108.0K |
| Group One Trading, L.P. | 3,069 | $31.8K |
| GWM Advisors LLC | 217 | $2.25K |
Not filed for Q3 2023 yet (1)
Institutions that held Theravance Biopharma, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 1,841,997 | $19.1M |